• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Opthamologist access

Anonymous

Guest
Hi

I am looking at a specialty opthamology sales position. How is the access to most opthamologists? Is it as bad as other medical areas?

Thanks in advance for help!
 




It's a non-issue . . . I suppose it could vary from region to region, but overall, access is not a problem. I called on Ophth for 6 years and loved, loved, loved it. Now back in primary care hell -- miss ophthalmology like nobody's business!! Good luck!!